Adjust text size
Nadar JS, Kale PP, Kadu P, Prabhavalkar KS, Dhangar R. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice. 2018, https://doi.org/10.1155/2018/982863
Rahate K, Bhatt LK, Prabhavalkar KS. SERCA stimulation: A potential approach in therapeutics. Chem Biol Drug Des 2020 Jan 95(1): 5-15.
<>6.Mandal A, Prabhavalkar KS, Bhatt LK. Gastrointestinal hormones in regulation of memory. Peptides. 2018 Apr;102:16-25.
Marathe PA, Raut SB, Satam SD, Shetty YC, Pooja SG, Raut AA, Kale PP, Rege NN. Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals. Journal of Ethnopharmacology. 2020 In press. https://doi.org/10.1016/j.jep.2020.113304. (Impact factor 3.6)
Jaiswal M, Kale PP. Mini review- Vanadium induced neurotoxicity and possible targets. Neurological Sciences. 2020;41:763-768. (Impact factor 2.4)
Rodrigues PS, Kale PP, Bhatt LK. Neuroimaging in Parkinson’s disease. Neurological Disorders and Imaging Physics, 2020, Volume 5. Chapter 11. [Book Chapter]
Palwankar SM, Kale PP, Kadu PK, Prabhavalkar K. Assessment of Antidiabetic Activity of Combination of Murraya koenigii Leaves Extract and Vitis vinifera Seeds Extract in Alloxan-induced Diabetic Rats. Journal of Reports in Pharmaceutical Sciences. 2020. 9:79-85.
Dhangar R, Kale PP, Kadu PK, Prabhavalkar K. Possible benefits of considering glutamate with melatonin or orexin or oxytocin as a combination approach in the treatment of anxiety. Current Pharmacology Reports. 2020;6:1-7.
John P, Kale PP. Prominence of oxidative stress in the management of Anti-tuberculosis drugs related hepatotoxicity. Drug Metabolism Letters. 2019; 13(2): 95-107. DOI: 10.2174/1872312813666190716155930
Bendale M, D'souza, Addepalli V, Kale PP. Effect of bupropion augmentation with minocycline in the treatment of depression. Acta Neurobiologiae Experimentalis. 2019, 79;217-224. DOI: 10.21307/ane-2019-019 (Impact factor 1.5)
Sakthivel JN, Kale PP, Kadu PK, Prabhavalkar K, Dhangar R. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice. Neurology Research International. 2018 (2018): 9828639. https://doi.org/10.1155/2018/9828639.
Vallikalayil RP, Kale PP, Savai J. Evaluation of Anxiolytic effect of Zonisamide and its combination with Bupropion in mice. Indian Journal of Experimental Biology. 2018 Jan; 56(1): 54-59. (Impact factor 1.47)
Bohra BS, Kale PP. Evaluation of nootropic effects of galantamine and sildenafil as a combination in mice. Indian Journal of Experimental Biology. 2018 Jan; 56(1):60-65. (Impact factor 1.47)
Bagwe SM, Kale PP, Bhatt LK, Prabhavalkar KS. Herbal Approach in the treatment of pancytopenia. Journal of Complementary & Integrative Medicine. 2017; 20160053. doi: 10.1515/jcim-2016-0053..
Sawantdesai NS, Kale PP, Savai J. Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice. Journal of Basic & Clinical Pharmacy. 2016;7:97-104. DOI 10.4103/0976-0105.189429 .
Kale PP, Addepalli V. Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice Indian Journal of Pharmacology. 2015;47(2):199-201. (Impact factor 0.9). DOI 10.4103/0253-7613.153430
Patel S, Kale PP, Addepalli V. Sarkar A, Savai J. Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice. Indian Journal of Pharmacology. 2015; 47(2):173-176. (Impact factor 0.9). DOI 10.4103/0253-7613.153424
Kale PP, Addepalli V, Sarkar A, Patel S, Savai J. The combination of antidepressant duloxetine with piracetam in mice does not produce enhancement of nootropic activity. Experimental Neurobiology. 2014;23(3):224-30. (Impact factor 3.81) DOI: 10.5607/en.2014.23.3.224
Kale PP, Addepalli V. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharmacology Biochemistry and Behavior. 2014;124:238-244. (Impact factor 2.5) DOI 10.1016/j.pbb.2014.06.005
Kale PP, Addepalli V. Enhancement of anxiolytic effect of duloxetine or bupropion by caffeine in mice. Journal of Caffeine Research. 2014;4(3):69-70. (Indexed in Pubmed, Thomson Reuters, etc.) DOI 10.1089/jcr.2014.0014
Kale PP, Addepalli V, Ghadawale S. Impact of pre-exposure of tail suspension on behavioural parameters like locomotion, exploration, and anxiety. Indian Journal of Experimental Biology. 2013;51(9):732-738. (Impact factor 1.47)
Kale PP, Addepalli V, Bafna PA, Prabhavalker K. Caffeine-induced augmentationof antidepressant therapy. Journal of Experimental and Clinical Medicine. 2010; 2(6):282-286. (Indexed in Scopus, etc.) DOI :10.1016/j.jecm.2010.09.001
1. Hemen S. Ved , Gaurav M. Doshi. A Review on Emerging Drug Targets in Treatment of Schizophrenia”, Current Drug Targets. 2020. June 2020; 21: 1. (IMPACT FACTOR: 2.632)